in Health, Environment & the Life Sciences
On December 4 and 5, 2023, the National Academies of Sciences, Engineering, and Medicine (NASEM) hosted a virtual workshop titled "On Leading a Lab: Strengthening Scientific Leadership in Responsible Research". This program is for research leaders who direct laboratories, centers, departments, or collaborations.
A recent study involving researchers with the Center for Clinical and Cognitive Neuropharmacology (CCCN), a Consortium member center, found that 60% of registered medical cannabis users in Minnesota had indications of "intractable pain," but that older and younger adults received significant differences in dosage.
Over 60 trainee and faculty members of the Masonic Institute for the Developing Brain (MIDB) presented their research at the annual Flux Congress last month located in Santa Rosa, California. The Congress is sponsored by the Flux Society, which advances the field of human brain development through professional engagement, research translation, and public discussions about the societal implications of work in the field. The 32 MIDB presentations showcased the Institute's wide-ranging research in developmental neuroscience research.
The Clinical and Translational Science Institute (CTSI) recently received $53.9 million in National Institutes of Health funding to find better, faster ways to bring scientific advances to real-world use. The seven-year award is one of the largest federal research grants the University of Minnesota has ever received and the University’s third Clinical and Translational Science Award (CTSA).
The Masonic Cancer Center (MCC) has retained its National Cancer Institute (NCI) designation as a comprehensive cancer center, the highest federal rating a cancer center can achieve. The MCC is one of only two comprehensive cancer centers in Minnesota and 53 in the nation. The rigorous and highly competitive NCI designation process is undertaken every five years. This is the sixth consecutive time MCC has received the designation, this time with its highest score to date.
The Center for Bioethics will present “Seen Yet Invisible: Lessons from Muslim Experiences at the Margins of Diversity, Equity and Inclusion in Healthcare,” on Friday, Sept. 23 from Noon - 1pm Central time. The webinar will feature Aasim I. Padela, MD, MSc, FACEP, Professor and Vice Chair for Research and Scholarship at the Medical College of Wisconsin, presenting on how religious identity is often overlooked in DEI and health equity conversations.
Pandemic triage plans that consider age, disability, comorbidities, and prolonged post-hospital survival when allocating scarce treatment resources may discriminate against minoritized racial and ethnic groups, older adults, and individuals with disabilities, according to a study published in the Journal of the American Medical Association Network Open (JAMA Network Open).
Ian Wolfe, PhD, MA, RN, is the lead author of a recent article in Pediatrics that reports on the results of an ethics conference workshop designed to identify and analyze policies, procedures, and practices in pediatric hospitals that contribute to structural racism.
Andrew Maynard, PhD, of Arizona State University’s (ASU) School for the Future of Innovation in Society, has teamed-up with ChatGPT to create an undergraduate course on ChatGPT Prompt Engineering (some of the course-related resources are available here).
Professor Francis Shen JD, PhD, co-authored a recent article in Nature Reviews Bioengineering reviewing the emergence and potential applications of portable low-field MRI technology. The article addresses translational, safety, and resource considerations. It also details how this technology may open up new opportunities for neuroimaging in conditions such as stroke, cardiac arrest, and multiple sclerosis, and pave the way for democratization of MRI.